Last week’s hot topic on BPH was Prostate Response to Dutasteride Treatment in BPH Patients May Depend on Testosterone Levels written by Alisa Woods.
This article focused on a research report from Japan which sheds light on individual responses to dutasteride, a commonly used medication to treat benign prostatic hyperplasia (BPH), and also suggests that the drug helps to relieve urinary symptoms even in people who don’t show a significant reduction in prostate volume. The paper, “Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction,” appeared on Feb. 18, 2016, in the journal The Aging Male.
Dutasteride may help to improve urinary symptoms, the study found, even when prostate volume is not substantially reduced. The work also sheds light on possible biological markers for predicting who will best respond to this drug.